Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1096522

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1096522

Brain Modalities and Software Market: Current Analysis and Forecast (2021-2027)

PUBLISHED:
PAGES: 243 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License)
USD 5099
PDF (Global License)
USD 7577

Add to Cart

Brain modalities and software market is expected to witness a CAGR of ~5% over the forecast period (2021-2027). brain modalities and software devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain modalities and software devices such as electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions. In addition, according to the World Health Organization (WHO), the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively. These stats show the need for brain modalities and Software devices in the global healthcare industry today. The market offers a wide range of devices to treat abnormal brain activities and restore their functioning, depending on the case.

The growth of this market is driven owing to the rising incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, and growth in the number of traumatic brain injuries. For instance, According to World Health Organization (WHO), in September 2021 more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. Also, in 2019, globally, 50 million people were diagnosed with epilepsy. According to World Health Organization (WHO), nearly 80% population live in low- and middle-income countries.According to the world health organization (WHO), the ratio of death in the U.S. with epilepsy as the underlying cause from 2015 to 2020. the death ratio for epilepsy was 0.6 per 100,000 population, a slight increase from a rate of 0.4 in the year 2015.

Epilepsy is a general term used to describe a group of related neurological disorders characterized by recurrent seizures. Seizures among epileptics can vary in frequency and seriousness and can last a few seconds or a few minutes. Some of the most common seizure triggers among epileptics include bright flashing lights, stress, lack of sleep, illness or fever, and alcohol, caffeine, and other drugs. In most cases, the cause of epilepsy is unknown, but the disorder can result from stroke, brain injury, brain tumors, or serious illness. Approximately 1.1 percent of the population of the U.S. currently lives with epilepsy, with the disorder occurring equally among men and women.

Vuno Co. Ltd., Fujifilm Holdings Corporation, Imaging Biometrics LLC, A.I. Analysis Inc., Aspect Imaging Ltd., IXICO plc, Mint Labs Inc., Medtronic, CAS Medical Systems, Inc., Dragerwerk AG & Co. KGaA. are some of the prominent players operating in the brain modalities and software market. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced products.

Insights Presented in the Report

Amongst by offering, the brain imaging modalities segment to hold significant share"

Based by offering, the brain modalities and software market is bifurcated into brain imaging modalities, and brain analysis software. Among these, the brain imaging modalities category held the largest share in the market. This is mainly due to the rising incidence of neurological, traumatic brain injuries, psychotic, and sleep disorders, the need for early diagnosis, and increasing patient awareness.

"Amongst by patient type, the traumatic brain injury (TBI) segment holds the major share"

Based on patient type, the market is categorized into adults, pediatrics & infants. Among these, the pediatrics & infants category is projected to witness significant growth during the forecast period. Some neurological conditions are inborn, caused by birthing mishaps, such as hemorrhage, asphyxia, hydrocephalus, a viral or bacterial infection contracted during pregnancy, delivery, or after birth, and use of alcohol or drugs during pregnancy. Furthermore, rising incidences of traumatic brain injuries is also a key factor driving the market.

"Amongst end-user, the diagnostic image centers segment holds the major share"

Based on end-users, the brain modalities and software devices market is segmented into hospitals & clinics, neurology centers, ambulatory surgery centers (ACS), and diagnostic image centers. The diagnostic image centers is expected to hold a dominant position during the forecast period. Brain modalities and software is a complex process, requiring expensive and advanced devices and equipment that are mainly found in diagnostic image centers. Additionally, brain modalities and software devices pose a considerable burden in terms of maintenance expenses on healthcare facilities, more than other end-users.

"North America signifies one of the largest markets of Brain Modalities and Software market"

For a better understanding of the market adoption, the report provides a detailed analysis of major regions and countries including North America (US, Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America is expected to dominate the brain modalities and software market due to the growing incidence of neurological diseases coupled with rising expenditure on development of advance products and systems for treatment of various neurological and other diseases. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to the increase in the geriatric population.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The brain modalities and software market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Product Code: UMHE21842

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stakeholders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Brain Modalities & Software Market
  • 2.2. Research Methodology of the Brain Modalities & Software Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Brain Modalities & Software Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BRAIN MODALITIES & SOFTWARE MARKET

6 BRAIN MODALITIES & SOFTWARE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY OFFERING

  • 7.1. Brain Imaging Modalities
  • 7.2. Brain Analysis Software

8 MARKET INSIGHTS BY PATIENT TYPE

  • 8.1. Adults
  • 8.2. Pediatrics & Infants

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Traumatic Brain Injury (TBI)
  • 9.2. Headache Disorders
  • 9.3. Epilepsy
  • 9.4. Sleep Disorders
  • 9.5. Parkinson's Disease
  • 9.6. Stroke
  • 9.7. Huntington's Disease
  • 9.8. Dementia
  • 9.9. Others

10 MARKET INSIGHTS BY END-USER

  • 10.1. Hospitals & Clinics
  • 10.2. Neurology Centers
  • 10.3. Ambulatory Surgery Centers
  • 10.4. Diagnostic Centers

11 MARKET INSIGHTS BY REGION

  • 11.1. North America Brain Modalities & Software Market
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe Brain Modalities & Software Market
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific Brain Modalities & Software Market
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World Brain Modalities & Software Market

12 BRAIN MODALITIES & SOFTWARE MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 BRAIN MODALITIES & SOFTWARE MARKET OPPORTUNITIES

14 BRAIN MODALITIES & SOFTWARE MARKET TRENDS

15 POLICY AND REGULATORY LANDSCAPE

16 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 16.1. Demand Side Analysis
  • 16.2. Supply Side Analysis

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Vuno Co. Ltd.
  • 18.2. Fujifilm Holdings Corporation
  • 18.3. Imaging Biometrics LLC
  • 18.4. A.I. Analysis Inc.
  • 18.5. Aspect Imaging Ltd.
  • 18.6. IXICO plc
  • 18.7. Mint Labs Inc.
  • 18.8. Medtronic plc
  • 18.9. CAS Medical Systems Inc.
  • 18.10. Dragerwerk AG & Co. KGaA.

19 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!